Article
Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia
24 Oct 2011
Abstract excerpt
There is remarkable heterogeneity in the clinical course and biological characteristics of patient subgroups with chronic lymphocytic leukemia (CLL). Mutations of key tumor suppressors (ATM, miR-15a/16-1 and TP53) have been identified in CLL, and these aberrations are important "drivers" of the disease and some of its clinical characteristics. While some mutations are associated with poor outcome [particularly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
